Creso Pharma signs UK-focused commercial agreement with Pharmacare Europe

Medical cannabis company Creso Pharma (ASX: CPH) has expanded its UK presence by signing a commercial agreement with UK-based Pharmacare Europe to market and distribute its proprietary cannaQIX product in the UK. CannaQIX is a hemp-based human nutraceutical product in a proprietary delivery formulation, containing organic full spectrum hemp extract with CBD, vitamins and zinc. Its prime application is […]